Persönlicher Kommentar zu bildgebenden Verfahren in der Diagnostik des Pankreaskarzinoms

Literatur

• 1 Dewitt J, Devereaux B M, Lehman G A. et al . Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review.  Clin Gastroenterol Hepatol. 2006;  4 717-725
• 2 Bipat S, Phoa S S, Delden O M. et al . Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis.  J Comput Assist Tomogr. 2005;  29 438-445
• 3 Sahani D V, Shah Z K, Catalano O A. et al . Radiology of pancreatic adenocarcinoma: current status of imaging.  J Gastroenterol Hepatol. 2008;  23 23-33
• 4 Schick van V, Franzius C, Beyna T. et al . Diagnostic impact of (18)F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound.  Eur J Nucl Med Mol Imaging. 2008;  DOI: 10.1007 /s00259 – 008-0818-x
• 5 Schima W, Ba-Ssalamah A, Goetzinger P. et al . State-of-the-art magnetic resonance imaging of pancreatic cancer.  Top Magn Reson Imaging. 2007;  18 421-429
• 6 Tamm E P, Bhosale P R, Lee J H. Pancreatic ductal adenocarcinoma: ultrasound, computed tomography, and magnetic resonance imaging features.  Semin Ultrasound CT MR. 2007;  28 330-338
• 7 Husband J E, Schwartz L H, Spencer J. et al . Evaluation of the response to treatment of solid tumours – a consensus statement of the International Cancer Imaging Society.  Br J Cancer. 2004;  90 2256-2260
• 8 Seitz K, Judmaier G. The extended repertoire of sonography: contrast enhancement, radio frequency ablation and puncture.  Ultraschall in Med. 2007;  28 158-160
• 9 Claudon M, Cosgrove D, Albrecht T. et al . Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008.  Ultraschall in Med. 2008;  29 28-44
• 10 Bauditz J, Bodamer A, Wermke W. Kontrastmittelsonographie: Sind nach der Diagnose Pankreaskarzinom weitere Untersuchungen erforderlich?.  Ultraschall in Med. 2006;  S27 31
• 11 D’Onofrio M, Malagò R, Gubello T. et al . Tumor vascularity at contrast-enhanced ultrasound (CEUS) of resectable ductal adenocarcinoma of the pancreas.  Ultraschall in Med. 2007;  28 S39
• 12 Hocke M, Topalidis T, Stallmach A. et al . The use of contrast enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer.  Ultraschall in Med. 2007;  28 S40
• 13 Ignee A, Braden B, Schuessler G. Improved differentiation of pancreatic tumours using contrast enhanced transabdominal ultrasound.  Ultraschall in Med. 2007;  28 S32
• 14 Dietrich C F, Ignee A, Braden B. et al . Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound.  Clin Gastroenterol Hepatol. 2008;  6 590-597
• 15 D’Onofrio M, Malagò R, Zamboni G. Comparison of contrast-enhanced ultrasonography and magnetic resonance imaging in displaying anatomic features of cystic pancreatic masses.  Ultraschall in Med. 2007;  28 S31
• 16 Grossjohann H S, Bachmann N M, Nielsen K R. et al . Evaluation of Contrast-Enhanced Ultrasound of the Pancreas Combined with Concurrent Hormone Stimulation.  Ultraschall in Med. 2007;  DOI: 10.1055 /s-2007-963 292
• 17 Saftoiu A, Vilmann P, Hassan H. et al . Analysis of endoscopic ultrasound elastography used for characterisation and differentiation of benign and malignant lymph nodes.  Ultraschall in Med. 2006;  27 535-542
• 18 Ignee A, Hirche T O, Barreiros A P. et al . Indications and limitations of tissue real-time elastography using endoscopic ultrasound in pancreatic disease.  Ultraschall in Med. 2008;  29 S1
• 19 Knottner R. 40 years of ultrasound real-time grayscale diagnostics.  Ultraschall in Med. 2006;  27 214-216